Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate.

IF 2.2 Q3 INFECTIOUS DISEASES
Angsana Phuphuakrat, Ekawat Pasomsub, Wasun Chantratita, Surakameth Mahasirimongkol, Sinee Disthabanchong, Somnuek Sungkanuparph, Sasisopin Kiertiburanakul
{"title":"Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate.","authors":"Angsana Phuphuakrat,&nbsp;Ekawat Pasomsub,&nbsp;Wasun Chantratita,&nbsp;Surakameth Mahasirimongkol,&nbsp;Sinee Disthabanchong,&nbsp;Somnuek Sungkanuparph,&nbsp;Sasisopin Kiertiburanakul","doi":"10.1177/23259582221134751","DOIUrl":null,"url":null,"abstract":"<p><p>Tenofovir disoproxil fumarate (TDF) associates with renal tubular dysfunction (RTD) in some people living with HIV (PLWH). We studied clinical and genetic factors associated with RTD in Thai PLWH receiving TDF. RTD was diagnosed in 13 of 65 (20%) patients. The median (interquartile range) age and CD4 cell counts were 43.8 (40.4-50.9) years and 554 (437-716) cells/mm<sup>3</sup>, respectively. The median duration of TDF use was 46.9 (31.5-54.1) months. Univariate logistic regression demonstrated body mass index (BMI), concomitant use of protease inhibitor (PI), hyperlipidemia, and homozygous C/C SNP rs1059751 of <i>ABCC4</i> gene as predisposing factors of RTD. In multivariate model, concomitant use of PI [adjusted odds ratio (aOR) 11.39; 95% confidence interval (CI), 1.59- 81.56; <i>P</i> = 0.015], hyperlipidemia (aOR 8.59; 95% CI, 1.46-50.40; <i>P</i> = 0.017), and BMI (aOR 0.76; 95% CI, 0.59-0.98; <i>P</i> = 0.037) remained associated with RTD in patients receiving TDF. PLWH receiving TDF with the presence of these factors should be closely monitored for RTD.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/c7/10.1177_23259582221134751.PMC9623366.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International Association of Providers of AIDS Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23259582221134751","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 1

Abstract

Tenofovir disoproxil fumarate (TDF) associates with renal tubular dysfunction (RTD) in some people living with HIV (PLWH). We studied clinical and genetic factors associated with RTD in Thai PLWH receiving TDF. RTD was diagnosed in 13 of 65 (20%) patients. The median (interquartile range) age and CD4 cell counts were 43.8 (40.4-50.9) years and 554 (437-716) cells/mm3, respectively. The median duration of TDF use was 46.9 (31.5-54.1) months. Univariate logistic regression demonstrated body mass index (BMI), concomitant use of protease inhibitor (PI), hyperlipidemia, and homozygous C/C SNP rs1059751 of ABCC4 gene as predisposing factors of RTD. In multivariate model, concomitant use of PI [adjusted odds ratio (aOR) 11.39; 95% confidence interval (CI), 1.59- 81.56; P = 0.015], hyperlipidemia (aOR 8.59; 95% CI, 1.46-50.40; P = 0.017), and BMI (aOR 0.76; 95% CI, 0.59-0.98; P = 0.037) remained associated with RTD in patients receiving TDF. PLWH receiving TDF with the presence of these factors should be closely monitored for RTD.

Abstract Image

Abstract Image

Abstract Image

接受富马酸替诺福韦二吡酯治疗的泰国艾滋病毒感染者肾小管功能障碍的危险因素
富马酸替诺福韦二氧吡酯(TDF)与一些HIV感染者(PLWH)的肾小管功能障碍(RTD)有关。我们研究了与接受TDF的泰国PLWH患者RTD相关的临床和遗传因素。65例患者中有13例(20%)被诊断为RTD。年龄和CD4细胞计数的中位数(四分位数范围)分别为43.8(40.4-50.9)岁和554(437-716)个细胞/mm3。TDF使用的中位持续时间为46.9(31.5-54.1)个月。单因素logistic回归显示,体重指数(BMI)、同时使用蛋白酶抑制剂(PI)、高脂血症和ABCC4基因纯合C/C SNP rs1059751是RTD的易感因素。在多变量模型中,同时使用PI[校正优势比(aOR) 11.39;95%置信区间(CI), 1.59 ~ 81.56;P = 0.015],高脂血症(aOR 8.59;95% ci, 1.46-50.40;P = 0.017), BMI (aOR 0.76;95% ci, 0.59-0.98;P = 0.037)仍然与接受TDF的患者的RTD相关。接受TDF的PLWH应密切监测这些因素是否存在RTD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
43
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信